REV 5901A

Description: REV 5901A (REV 5901 HCl) is an orally active leukotriene receptor antagonist and 5-lipoxygenase inhibitor with antimicrobial activity that attenuates colon cancer growth in mice.REV 5901A has been used in studies of asthma and myocardial infarction. REV 5901A is used to study asthma and myocardial infarction. Target: Lipoxygenase, Antibiotic, Leukotriene Receptor. Smiles: Cl.OC(C=1C=CC=C(OCC2=NC=3C=CC=CC3C=C2)C1)CCCCC. References: Inwegen RGV, et al. REV 5901: an orally effective peptidoleukotriene antagonist, detailed biochemical/pharmacological profile. J Pharmacol Exp Ther. 1987 Apr,241(1):117-24.